A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma (NCT06502366)
A Randomized, Placebo-controlled, Double-blind, Multicenter, 12-Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared With BDA Delivered by MDI HFA in Participants With Asthma
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the currently approved propellant HFA in participants with asthma.
Who can join: Review the eligibility criteria below.
Location: Research Site โ Mobile, Alabama
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (128 Sites)
Showing the first 25 of 128 sites.
- Research Site โ Mobile, Alabama
- Research Site โ Sheffield, Alabama
- Research Site โ Phoenix, Arizona
- Research Site โ Little Rock, Arkansas
- Research Site โ Encinitas, California
- Research Site โ Fullerton, California
- Research Site โ Gardena, California
- Research Site โ Huntington Beach, California
- Research Site โ La Mesa, California
- Research Site โ Los Angeles, California
- Research Site โ Los Angeles, California
- Research Site โ Sacramento, California
- Research Site โ San Bernardino, California
- Research Site โ San Diego, California
- Research Site โ San Jose, California
- Research Site โ Santa Ana, California
- Research Site โ Stockton, California
- Research Site โ Westminster, California
- Research Site โ Englewood, Colorado
- Research Site โ Wheat Ridge, Colorado
- Research Site โ Washington D.C., District of Columbia
- Research Site โ Boynton Beach, Florida
- Research Site โ Miami, Florida
- Research Site โ Tallahassee, Florida
- Research Site โ Tampa, Florida
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Asthma
- Investigating Dupilumab's Effect in Asthma by Genotype โ Boston, Massachusetts
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma โ Bakersfield, California
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma โ Saraland, Alabama
- Reduce IDentified UNcontrolled Asthma โ San Diego, California
- A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma โ Little Rock, Arkansas
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study โ La Jolla, California
Explore by condition: All Asthma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.